483
ClinSync Clinical Research Pvt LtdFDA 483 - ClinSync Clinical Research Pvt Ltd
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of ClinSync Clinical Research Pvt. Ltd. in Hyderabad, India, on January 10-13, 2020, revealed a significant issue regarding the retention of reserve samples. The firm failed to retain representative reserve samples of investigational product from multiple shipments used in studies submitted to the FDA. Additionally, there were discrepancies in the documentation of product shipments in clinical study reports.
- Product Type
- Drugs
Open in Dashboard
ID · ad9ab895-1321-4f6d-b2b6-727417491e01